Gary Taylor
Stock Analyst at TD Cowen
(0.46)
# 4,378
Out of 5,000 analysts
260
Total ratings
44.2%
Success rate
-4%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGRY Surgery Partners | Rated: Buy | $36 → $19 | $13.98 | +35.91% | 9 | Aug 11, 2026 | |
| ACHC Acadia Healthcare Company | Rated: Buy | $91 → $24 | $27.75 | -13.51% | 14 | Feb 26, 2026 | |
| DVA DaVita | Maintained: Hold | $139 → $157 | $179.39 | n/a | 26 | May 19, 2025 | |
| ELV Elevance Health | Maintained: Buy | $589 | $405.84 | n/a | 15 | Oct 16, 2024 | |
| UNH UnitedHealth Group | Maintained: Buy | $601 | $399.66 | n/a | 16 | Oct 11, 2024 | |
| AGL agilon health | Reiterated: Hold | $6 | $87.38 | n/a | 10 | Aug 5, 2024 | |
| CI The Cigna Group | Maintained: Buy | $400 | $282.84 | n/a | 12 | Jul 29, 2024 | |
| HCA HCA Healthcare | Maintained: Buy | $371 → $360 | $402.06 | n/a | 21 | Apr 30, 2024 | |
| MOH Molina Healthcare | Maintained: Buy | $453 → $412 | $202.62 | n/a | 14 | Apr 30, 2024 | |
| UHS Universal Health Services | Maintained: Hold | $181 → $183 | $167.49 | n/a | 21 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $427 → $396 | $400.97 | n/a | 19 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $13.59 | n/a | 6 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $26 | $20.72 | n/a | 7 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $8.5 | $12.89 | n/a | 8 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $91 | $67.34 | n/a | 12 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $9.41 | n/a | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $6 | $30.33 | n/a | 4 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1.75 | $4.30 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $10.81 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $23.85 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $32 → $20 | $258.53 | n/a | 7 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $20 | $26.86 | n/a | 5 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $2.90 | n/a | 9 | Dec 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $74 | $240.80 | n/a | 4 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $114 → $132 | $331.66 | n/a | 4 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Nov 2, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $50.81 | n/a | 1 | May 11, 2009 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $20.86 | n/a | 1 | Jan 27, 2009 |
Surgery Partners
Aug 11, 2026
Rated: Buy
Price Target: $36 → $19
Current: $13.98
Upside: +35.91%
Acadia Healthcare Company
Feb 26, 2026
Rated: Buy
Price Target: $91 → $24
Current: $27.75
Upside: -13.51%
DaVita
May 19, 2025
Maintained: Hold
Price Target: $139 → $157
Current: $179.39
Upside: n/a
Elevance Health
Oct 16, 2024
Maintained: Buy
Price Target: $589
Current: $405.84
Upside: n/a
UnitedHealth Group
Oct 11, 2024
Maintained: Buy
Price Target: $601
Current: $399.66
Upside: n/a
agilon health
Aug 5, 2024
Reiterated: Hold
Price Target: $6
Current: $87.38
Upside: n/a
The Cigna Group
Jul 29, 2024
Maintained: Buy
Price Target: $400
Current: $282.84
Upside: n/a
HCA Healthcare
Apr 30, 2024
Maintained: Buy
Price Target: $371 → $360
Current: $402.06
Upside: n/a
Molina Healthcare
Apr 30, 2024
Maintained: Buy
Price Target: $453 → $412
Current: $202.62
Upside: n/a
Universal Health Services
Apr 30, 2024
Maintained: Hold
Price Target: $181 → $183
Current: $167.49
Upside: n/a
Apr 2, 2024
Maintained: Buy
Price Target: $427 → $396
Current: $400.97
Upside: n/a
Mar 1, 2024
Rated: Buy
Price Target: $8
Current: $13.59
Upside: n/a
Mar 1, 2024
Rated: Buy
Price Target: $30 → $26
Current: $20.72
Upside: n/a
Mar 1, 2024
Rated: Hold
Price Target: $6 → $8.5
Current: $12.89
Upside: n/a
Feb 12, 2024
Maintained: Buy
Price Target: $84 → $91
Current: $67.34
Upside: n/a
Nov 10, 2023
Maintained: Hold
Price Target: $3.5
Current: $9.41
Upside: n/a
Feb 13, 2023
Rated: Hold
Price Target: $3 → $6
Current: $30.33
Upside: n/a
Nov 14, 2022
Maintained: Hold
Price Target: $3 → $1.75
Current: $4.30
Upside: n/a
Nov 14, 2022
Maintained: Hold
Price Target: $6 → $7
Current: $10.81
Upside: n/a
Jan 11, 2021
Initiated Coverage: Buy
Price Target: $21
Current: $23.85
Upside: n/a
Sep 21, 2020
Downgraded: Sell
Price Target: $32 → $20
Current: $258.53
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $55 → $20
Current: $26.86
Upside: n/a
Dec 14, 2017
Downgraded: Sell
Price Target: n/a
Current: $2.90
Upside: n/a
Jan 30, 2015
Maintained: Hold
Price Target: $65 → $74
Current: $240.80
Upside: n/a
Jan 5, 2015
Rated: Buy
Price Target: $114 → $132
Current: $331.66
Upside: n/a
Nov 2, 2010
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
May 11, 2009
Upgraded: Buy
Price Target: n/a
Current: $50.81
Upside: n/a
Jan 27, 2009
Upgraded: Buy
Price Target: n/a
Current: $20.86
Upside: n/a